Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/12/1997CN1164389A Extended release formulation
11/12/1997CN1164388A Pharmaceutical composition for treatment of dementia
11/12/1997CN1164387A Stable carotenoid emulsions suitable for parenteral administration
11/12/1997CN1036398C Therapeutic nucleosides
11/12/1997CN1036396C Process for preparing (E)-3-£2-n-butyl-1-{(4-carboxyl-phenyl)methyl}-1H-imidazol-5-yl}-2-(2-thienyl) methyl-2-acrylic methylsulfonate
11/12/1997CN1036395C Method for preparation of piperazine derivatives
11/12/1997CN1036394C Method for preparation of carbostyril derivatives
11/12/1997CN1036393C 7-(2-aminoethyl)-benzothiazolones
11/12/1997CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/12/1997CN1036389C Phenylacetyl deriv. of 4-amino-2,6-dimethyl phenylsulfonyl-nitro-methane or preparing process thereof
11/11/1997US5686623 Method for preparing taxane derivatives
11/11/1997US5686621 Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
11/11/1997US5686615 Stereoselective preparation of substituted piperidines
11/11/1997US5686614 Preparation of chiral 5-aminocarbonyl-5H-dibenzo a,d!cyclohepten-5,10-imines by optical resolution
11/11/1997US5686609 Aromatic amine compounds, Their method of preparation and pharmaceutical compositions in which they are present
11/11/1997US5686597 Thrombin receptor homolog
11/11/1997US5686586 Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same
11/11/1997US5686562 Diagnosis and treatment of cancer
11/11/1997US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997US5686495 Substituted hydrazinedicarboximidamides and methods of use thereof
11/11/1997US5686494 Aminobenzamide compound
11/11/1997US5686493 Method for protecting against endotoxin-induced shock using ornithine
11/11/1997US5686491 Infant formula
11/11/1997US5686489 Alpha hydroxyacid esters for skin aging
11/11/1997US5686488 Polyethoxylated castor oil products as anti-inflammatory agents
11/11/1997US5686487 Treatment of cataract with 15-keto-prostaglandin compounds
11/11/1997US5686486 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections
11/11/1997US5686485 Physiologically active EI-1941 compounds
11/11/1997US5686483 Aminoalkyloximes
11/11/1997US5686480 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
11/11/1997US5686479 Immunosuppressive drug
11/11/1997US5686478 Endothelin antagonists
11/11/1997US5686477 5-(arloxymethyl)oxazolines
11/11/1997US5686476 Methods of inhibiting Alzheimer's Disease
11/11/1997US5686475 Application of riluzole in the treatment of mitochondrial diseases
11/11/1997US5686473 Treating parkinson*s disease, alzheimer*s disease, dementia and pain
11/11/1997US5686472 Inhibitors of farnesyl-protein transferase
11/11/1997US5686471 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/11/1997US5686468 2-phenyl-3-aroylbenzothiophenes
11/11/1997US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997US5686465 Sex steroid activity inhibitors
11/11/1997US5686464 3,3-diphenylpropylamines, their use and preparation
11/11/1997US5686463 Oxadiazoles useful in the treatment of senile dementia
11/11/1997US5686462 Anti-inflammatory method
11/11/1997US5686461 Inhibition of nmda induced convulsions
11/11/1997US5686460 Antiinflammatory agents, analgesics
11/11/1997US5686459 Anticoagulants
11/11/1997US5686458 Quinazoline deriviates for treating peptic ulcer
11/11/1997US5686457 Pyrrolopyrimidine derivatives having pharmacological activity
11/11/1997US5686456 Methods of treating pneumocystis carinii pneumonia
11/11/1997US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997US5686454 Preventing labor, vasodilation, diuresis, hypotensive agents, anticoagulants, treating dysmenorrhea
11/11/1997US5686451 Combination of an ace inhibitor and a diuretic
11/11/1997US5686450 Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
11/11/1997US5686449 1,5-benzodiazepines useful as gastrinor CCK-antagonists
11/11/1997US5686448 Treatment of virus infections with ganglionic blocking agents
11/11/1997US5686447 Aminoalkyloximes for treating depression and affective disorders
11/11/1997US5686446 Antidepressants, obsessive compulsive disorders
11/11/1997US5686444 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/11/1997US5686441 Penam sulfones as β-lactamase inhibitors
11/11/1997US5686440 Containing lactic acid as a solubilizer and an additive
11/11/1997US5686439 Chelate complexes and processes for their preparation
11/11/1997US5686438 Administering dehydroepiandrosterone or derivative
11/11/1997US5686437 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
11/11/1997US5686435 Vitamin D amide derivatives
11/11/1997US5686434 3-aryl-2-isoxazolines as antiinflammatory agents
11/11/1997US5686432 Use of some glycosaminoglycans in the peritoneal dialysis
11/11/1997US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997US5686429 Method for providing nutrition to elderly patients
11/11/1997US5686428 Pharmaceutical composition
11/11/1997US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
11/11/1997US5686425 Composition and method for revitalizing scar tissue
11/11/1997US5686424 For treating inflammation
11/11/1997US5686421 Hydantoin derivates
11/11/1997US5686414 Methods of treating conditions associated with corneal transplantation
11/11/1997US5686289 Seeding hollow fibers with renal tubule cells, culturing in presence of retinoic acid and epidermal growth factor, cell differentiation
11/11/1997US5686279 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
11/11/1997US5686245 Methods for screening for agents which modulate telomere length
11/11/1997US5686116 Administering a group iiia element-containing compound
11/11/1997US5686109 Antipyretic analgesic composition
11/11/1997US5686105 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
11/11/1997US5686104 Stable oral CI-981 formulation and process of preparing same
11/11/1997US5686100 Prophylactic and therapeutic treatment of skin sensitization and irritation
11/11/1997US5686098 Active substance patch for the release of estradiol to the skin
11/11/1997US5686097 Hormone replacement therapy, glycerol monolaurate, lauryl lactate
11/11/1997US5686095 Method of treating canker sores
11/11/1997US5686089 Tissue moisturizing and antimicrobial compositions
11/11/1997US5686086 External skin treatment composition
11/11/1997US5686083 Alpha-ketobutyric acid, balsam extract, carotene, acetone, collodion, keratolytic action
11/11/1997US5686082 Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract
11/11/1997US5686080 Parasitic helminth p4 proteins
11/11/1997US5686065 Topical siloxane sunscreen compositions having enhanced performance and safety
11/11/1997US5685832 Cellulose ester wound dressing
11/11/1997US5685195 Crank assembly for a screen wiper drive of an automotive vehicle
11/11/1997CA2130563C 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
11/11/1997CA2024502C Dosage form for administering oral hypoglycemic glipizide
11/11/1997CA2023430C Salts of optically active 4-hydroxy-8- (3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo[1,5-a]-1,3,5- triazines and a process for production thereof
11/11/1997CA2009886C "1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
11/11/1997CA1339533C T-butyl ergoline derivatives
11/10/1997CA2204582A1 Anti-cataract agent